ArticleBiosensors2025
Real-Time Monitoring of NIH/3T3 Cell Growth and Drug Reaction Using Impedance Biosensors and Comparison with Biological Assays.
Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Impedance biosensors are manufactured on glass slides using a semiconductor process to monitor cell growth and cell-drug reactions in real time, and the results are compared with biological assay results to confirm the validity of impedance measurement method. Approximately 10,000 cells per well were cultured for 48 h, after which 6.67 μg/mL puromycin was injected to observe apoptosis over the following 48 h. A frequency sweep from 1 kHz to 1 MHz was performed to determine the optimal frequency range, identifying 367-440 kHz as the most sensitive for detecting impedance changes. Impedance was measured every 10 min for 96 h. Capacitance gradually increased during cell proliferation, while after drug administration, a transient increase occurred within 9 h, followed by a rapid decline, indicating cell death within 24 h. The sensor utilized Electrical Cell-substrate Impedance Sensing (ECIS) to detect real-time changes in cell status without the need for staining or destruction. Comparison with conventional biological assays such as MTS and FACS confirmed that the impedance biosensor provided higher sensitivity and quantitative accuracy in monitoring both cell proliferation and apoptosis. This study demonstrates that the developed biosensor enables label-free, non-invasive, and continuous monitoring of cellular behaviors with acceptable coincidence with 3 different biological assay results. Impedance biosensor presents a promising alternative to conventional biological assays and offers potential applications in drug screening, cytotoxicity evaluation, and real-time biological monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.